Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 26;8(35):59648-59657.
doi: 10.18632/oncotarget.19570. eCollection 2017 Aug 29.

Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma

Jianping Xiong  1 , Yaqin Wang  2 , Hanchun Huang  1 , Jin Bian  1 , Anqiang Wang  1 , Junyu Long  1 , Ying Zheng  3 , Xinting Sang  1 , Yiyao Xu  1 , Xin Lu  1 , Haitao Zhao  1
Affiliations

Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma

Jianping Xiong et al. Oncotarget. .

Abstract

Studies have reported that cholecystectomy may increase the risk of cholangiocarcinoma. However, this association is controversial. Thus, we conducted a systematic review and meta-analysis to explore the relationship between cholecystectomy and the risk of cholangiocarcinoma. Relevant studies were identified by searching PubMed, EMBASE, ISI Web of Science published before February 2017. We used the random effects model proposed by DerSimonian and Laird to quantify the relationship between cholecystectomy and risk of cholangiocarcinoma. Publication bias was evaluated using funnel plots, Begg's and Egger's tests. Subgroup and sensitivity analyses were performed to validate the stability of the results. 16 articles, comprising 220,376 patients with cholecystectomy and 562,392 healthy controls, were included in our research. Our meta-analysis suggested that the risk of cholangiocarcinoma was significantly higher in the cholecystectomized patients in comparison with healthy controls, with heterogeneity among studies (summary odds ratio [OR] = 0.72; confidence interval [CI] = 0.55-0.90; I2 = 69.5%). Additionally, this association was also observed in cohort studies (OR = 0.83; 95% CI = 0.73-0.94) and case-control studies (OR = 0.60; 95% CI = 0.40-0.80). However, When the intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma were analyzed separately, the present study only indicated cholecystectomy was associated with increased the risk of extrahepatic cholangiocarcinoma (OR = 1.19; 95% CI = 0.32-2.05), rather than intrahepatic cholangiocarcinoma (OR = 1.19; 95% CI = 0.32-2.05). In conclusion, cholecystectomy was associated with a significant 54% increase in the risk of cholangiocarcinoma, especially in the extrahepatic cholangiocarcinoma.

Keywords: biliary tract neoplasms; cholangiocarcinoma; cholecystectomy; cholecystolithiasis; meta-analysis.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST Declaration of personal interests: None

Figures

Figure 1
Figure 1. The process of study selection for the meta-analysis
Figure 2
Figure 2. Forrest plot showing the relationship between cholecystectomy and the risk of cholangiocarcinoma
Points represent the risk estimates for each individual study. Horizontal lines represent 95% confidence intervals, and diamonds represent the summary risk estimates with 95% confidence intervals. ICC, intrahepatic cholangiocarcinoma. ECC, extrahepatic cholangiocarcinoma. CI, confidence interval. ES, effect size.
Figure 3
Figure 3. Sensitivity analysis of the association between cholecystectomy and the risk of cholangiocarcinoma
Figure 4
Figure 4. Funnel plot of studies included in the meta-analysis of the relationships between cholecystectomy and the risk of cholangiocarcinoma
Logor: Log odds ratio. SE: standard error.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368:230–239. - PubMed
    1. Kratzer W, Mason RA, Kachele V. Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound. 1999;27:1–7. - PubMed
    1. Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol. 2005;2:423–433. - PubMed
    1. Wang DQ, Cohen DE, Carey MC. Biliary lipids and cholesterol gallstone disease. J Lipid Res. 2009;50:S406–S411. - PMC - PubMed
    1. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep. 2005;7:132–140. - PubMed